ホーム
>
薬理と治療(JPT)
>
JPT ONLINE
> RCT・過去の臨床試験論文より
■JPT-online■
Placebo-controlled double-blind study of recombinant growth hormone for adult patients with growth hormone deficiency
Late phase II study of sepimostat mesilate(FUT-187)in postgastrectomy reflux esophagitis
-Clinical optimum dose in a double blind study-
Pharmacokinetic interaction between ampiroxicam and antiacid
Phase I study of a new antianxiety drug,SC-48274
The phase I study of high moleculer weight sodium hyaluronate(NRD101), a new anti-arthritis agent
A phase I study of calcium mupirocin 2% nasal ointment
-Safety and pharmacokinetic profile of mupirocin following nasal application in healthy male Japanese subjects-
A phase I study of granisetron hydrochloride(1)
-The safety of single oral administration in healthy Japanese subjects-
Clinical Evaluation of RPY-005, a low molecular weight heparin, for extracorporeal circulation during hemodialysis in patients with chronic renal insufficiency
-A double-blind cross-over comparative study with heparin-
Phase I study of vamicamide(1)
-Single-and multiple dose studies-
Phase I study of vamicamide(2)
-Single-and multiple dose studies-
Safety tolerance and pharmacokinetics of milrinone in phase I study in healthy male apanese subjects(2)
-After intravenous infusion-
The effect of nizatidine on gastric emptying and plasma gastrin concentration in patients with peptic ulcer
A phase 1 clinical study of EPOCH(epoetin beta)
-A multiple subcutaneous does study-
Clinical study of triazolam on sleep disorders in psychiatric aspect
-Comparative cross-over study with zopiclone-
Evaluation of pharmacokinetics of sustained release formulation of bunazosin(E1015) compared to sugar-coated plain tavlets(Detantol )and effect of food on pharmacokinetics of E1015
Results of phase I multiple dose study with NB-818,a new calcium channel blocker
Skin reactions to nitrate tapes at the early stage of application
Ursodeoxycholic acid for chronic non-A,non-B hepatitis
-A dose-response study-
Phase I Study(single administration)of CBM 36-733